Richard Neubig,
Professor and Chair,
Michigan State University
Richard Neubig, MD, PhD studied Chemistry at the University of Michigan then received his MD and PhD degrees from Harvard Medical School in the Harvard-MIT Program in Health Sciences and Technology in 1981. He trained in Internal Medicine at the University of Michigan where he joined the faculty in Pharmacology and Internal Medicine (Hypertension Division) in 1984. His work focuses on G protein coupled receptor signaling mechanisms and recently on Regulators of G protein Signaling (RGS proteins). In 2004, he co-founded the Center for Chemical Genomics (HTS lab) at the University of Michigan and in 2012 became the first director of the UM Center for the Discovery of New Medicines. In 2013, he moved to Michigan State University as Professor and Chair of Pharmacology and Toxicology. He is currently the President of ASPET (the American Society of Pharmacology and Experimental Therapeutics). His efforts in Drug Discovery have focused on challenging drug targets such as protein-protein interactions and gene transcription regulation mechanisms.
|
|
|